$ARAT
Arax Holdings Corp

2024 Q2 Form 10-Q Financial Statement

#000175392624000903 Filed on May 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $301.8K $226.9K $226.9K
YoY Change 33.0% 0.0%
Cost Of Revenue $0.00
YoY Change
Gross Profit $301.8K $226.9K
YoY Change 33.0%
Gross Profit Margin 100.0% 100.0%
Selling, General & Admin $87.54K $189.9K $70.40K
YoY Change -92.76% -10.58% -30.18%
% of Gross Profit 29.01% 83.68%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $151.00
YoY Change
% of Gross Profit 0.05%
Operating Expenses $87.54K $189.9K -$3.084M
YoY Change -92.76% -10.58% -3158.36%
Operating Profit $214.2K $37.02K
YoY Change -121.83% 154.49%
Interest Expense -$887.00 $0.00
YoY Change -96.93%
% of Operating Profit -0.41% 0.0%
Other Income/Expense, Net -$1.150K -$80.00
YoY Change -99.89%
Pretax Income $213.3K -$151.00 -$15.24M
YoY Change -179.51% -99.99% 15014.29%
Income Tax $0.00
% Of Pretax Income
Net Earnings $213.3K $35.87K -$15.24M
YoY Change -1735.07% -124.14% 15014.29%
Net Earnings / Revenue 70.7% 15.81% -6716.8%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 -$0.09
COMMON SHARES
Basic Shares Outstanding 127.6M shares 82.81M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $95.09K $3.030K $1.449M
YoY Change
Cash & Equivalents $95.09K $3.026K $1.449M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $755.6K $453.8K $227.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $850.7K $456.9K $1.676M
YoY Change 56.69% 1538.27%
LONG-TERM ASSETS
Property, Plant & Equipment $1.208K $1.360K $1.510K
YoY Change
Goodwill
YoY Change
Intangibles $268.0K $268.0K
YoY Change
Long-Term Investments $437.4K $437.4K
YoY Change
Other Assets $169.4K $0.00
YoY Change
Total Long-Term Assets $6.737M $6.737M $5.472M
YoY Change -64.55% 2869.41%
TOTAL ASSETS
Total Short-Term Assets $850.7K $456.9K $1.676M
Total Long-Term Assets $6.737M $6.737M $5.472M
Total Assets $7.588M $7.194M $7.148M
YoY Change -61.18% 2723.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $181.2K $100.0K $100.0K
YoY Change 11052.18%
Accrued Expenses $114.4K $110.6K $100.4K
YoY Change 163.56% 201.66% -14.11%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $453.3K $268.4K $258.1K
YoY Change 3.62% -76.51% 47.82%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $453.3K $268.4K $258.1K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $453.3K $268.4K $258.1K
YoY Change -52.58% -80.78% 47.82%
SHAREHOLDERS EQUITY
Retained Earnings -$23.07M -$19.39M -$19.42M
YoY Change 946.91% 909.48% 2109.61%
Common Stock $12.78K $126.2K $126.2K
YoY Change -88.33% 1120.72% 1120.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.134M $6.926M $6.890M
YoY Change
Total Liabilities & Shareholders Equity $7.588M $7.194M $7.148M
YoY Change -61.18% 2723.71%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income $213.3K $35.87K -$15.24M
YoY Change -1735.07% -124.14% 15014.29%
Depreciation, Depletion And Amortization $151.00
YoY Change
Cash From Operating Activities -$2.940K -$180.6K -$14.95M
YoY Change -99.75% -38.26%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $1.265M $5.033M
YoY Change
Acquisitions
YoY Change
Other Investing Activities $18.55M
YoY Change
Cash From Investing Activities $0.00 -$1.265M $13.52M
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 95.00K 2.716M
YoY Change -99.53%
NET CHANGE
Cash From Operating Activities -2.940K -$180.6K -14.95M
Cash From Investing Activities 0.000 -$1.265M 13.52M
Cash From Financing Activities 95.00K 2.716M
Net Change In Cash 92.06K -$1.446M 1.286M
YoY Change -83.19% -5284.29%
FREE CASH FLOW
Cash From Operating Activities -$2.940K -$180.6K -$14.95M
Capital Expenditures $0.00 $1.265M $5.033M
Free Cash Flow -$2.940K -$1.446M -$19.98M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
usd
CY2023Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q1 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
usd
CY2024Q1 arat Increase Decrease In Derivative Interest
IncreaseDecreaseInDerivativeInterest
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
usd
CY2024Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
CY2023Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19386716 usd
CY2024Q1 us-gaap Contractual Obligation
ContractualObligation
0 usd
CY2023Q4 us-gaap Contractual Obligation
ContractualObligation
0 usd
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-01-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
333-185928
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
ARAX HOLDINGS CORP.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
99-0376721
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
820 E Park Ave
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Bldg. D200
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Tallahassee
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32301
CY2024Q1 dei City Area Code
CityAreaCode
850
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
254-1161
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
127588506 shares
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3026 usd
CY2024Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
453837 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
456863 usd
CY2024Q1 us-gaap Land And Land Improvements
LandAndLandImprovements
1359 usd
CY2023Q4 us-gaap Land And Land Improvements
LandAndLandImprovements
1510 usd
CY2024Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
6298452 usd
CY2023Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
5033332 usd
CY2024Q1 us-gaap Long Term Investments
LongTermInvestments
437373 usd
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
437373 usd
CY2024Q1 us-gaap Assets
Assets
7194047 usd
CY2023Q4 us-gaap Assets
Assets
7147934 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
100000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
100000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
110623 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
100378 usd
CY2024Q1 us-gaap Notes Payable Current
NotesPayableCurrent
57756 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
57756 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
268378 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
258134 usd
CY2024Q1 us-gaap Liabilities
Liabilities
268378 usd
CY2023Q4 us-gaap Liabilities
Liabilities
258134 usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
10000 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
10000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
126160534 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
126160534 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10335294 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10335294 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
126161 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
126161 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
26176224 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
26176224 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19386716 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19422584 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
6925669 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
6889800 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7194047 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7147934 usd
CY2024Q1 us-gaap Revenues
Revenues
226886 usd
CY2023Q1 us-gaap Revenues
Revenues
226886 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
189868 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
212340 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
189868 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
212340 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
37018 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
14546 usd
CY2024Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
1264969 usd
CY2023Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
1047879 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-151 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1033333 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
35868 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-1033333 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
82811424 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10335294 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
6889800 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
35868 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
6925669 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-174625 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-148613 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1141564 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
35868 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-23616 usd
CY2024Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
226886 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-16346 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
10396 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7270 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-180622 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 usd
CY2024Q1 us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
1265120 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1265120 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1445742 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1448768 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3026 usd
CY2024Q1 arat Working Capital Deficit
WorkingCapitalDeficit
6925669 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_z5kX5xNI4rOd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zL3Q3XnGcXLd">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</span></p>
CY2024Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000000 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
126160534 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
126160534 shares
CY2024Q1 us-gaap Other Receivables
OtherReceivables
57756 usd
CY2023Q4 us-gaap Other Receivables
OtherReceivables
57756 usd

Files In Submission

Name View Source Status
0001753926-24-000903-index-headers.html Edgar Link pending
0001753926-24-000903-index.html Edgar Link pending
0001753926-24-000903.txt Edgar Link pending
0001753926-24-000903-xbrl.zip Edgar Link pending
arat-20240131.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g084117_10q.htm Edgar Link pending
arat-20240131_cal.xml Edgar Link unprocessable
arat-20240131_def.xml Edgar Link unprocessable
arat-20240131_lab.xml Edgar Link unprocessable
arat-20240131_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
g084117_ex31-1.htm Edgar Link pending
g084117_ex31-2.htm Edgar Link pending
g084117_ex32-1.htm Edgar Link pending
g084117_ex32-2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
g084117_10q_htm.xml Edgar Link completed